Hideo Kunito
Japanese Red Cross Medical Center(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Advanced Proteomics Techniques and Applications, Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research
Most-Cited Works
- → Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung Cancer(2007)57 cited
- → The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features(2018)9 cited
- → Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes(1996)2 cited
- Deletional mutant EGFR detected in circulating tumor-derived DNA from lung cancer patients treated with gefitinib.(2005)
- [Growth factor and signal transduction in lung cancer cell].(2000)